leflunomide has been researched along with Brain Disorders in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Didier, PJ | 1 |
| Adrián, ML | 1 |
| Paola, SA | 1 |
| Mauricio, FS | 1 |
| Omar, CS | 1 |
| Liset, RY | 1 |
| Luis, RJ | 1 |
1 other study available for leflunomide and Brain Disorders
| Article | Year |
|---|---|
CLIPPERS syndrome responsive to Leflunomide: A case report.
Topics: Adult; Brain Diseases; Cerebellum; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammation | 2018 |